% | $
Quotes you view appear here for quick access.

Sucampo Pharmaceuticals, Inc. Message Board

  • biotech_venture_capitalist biotech_venture_capitalist Jan 10, 2013 7:22 AM Flag

    Well, with Sucampo having 6 million scrips written over six years, the FDA should not have any safety issues with Amitiza for OIC

    This should provide them a huge leg up for approval as long as we made the efficacy goals. This would be a game changing event for SCMP..

    Sentiment: Strong Buy

12.93-0.04(-0.31%)2:24 PMEDT